Schizophrenia in late life: emerging issues.
Schizophrenia in late life is emerging as a major public health concern worldwide. We discuss several areas of research and clinical care that are particularly pertinent to older persons with schizophrenia, including the public health challenge and the cost of care. We then discuss clinical issues relevant to late-life schizophrenia (course of illness and cognition), medical care and comorbidity in older psychiatric patients (general and illness-related), and treatment concerns related to the use of atypical antipsychotics in older persons with psychosis (efficacy and side effects). Clinical care for this ever-increasing segment of our population requires special consideration of the unique characteristics of older persons with schizophrenia.
Folsom
David P
DP
University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0664, USA.
Lebowitz
Barry D
BD
Lindamer
Laurie A
LA
Palmer
Barton W
BW
Patterson
Thomas L
TL
Jeste
Dilip V
DV
D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000627:therapeutic use; D005853:Geriatrics; D006299:Health Services for the Aged; D006801:Humans; D012559:Schizophrenia / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy
D014150:Antipsychotic Agents